This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Fondazione Telethon, Ospedale San Raffaele S.r.l., Other. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2012-2013
Title: Manuela Battaglia: Innovator in Immunology
Introduction
Manuela Battaglia is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of immunology, particularly in the development of methods for treating autoimmune diseases. With a total of 2 patents to her name, her work has the potential to impact the treatment of various immune-related conditions.
Latest Patents
Manuela Battaglia's latest patents include a method for expanding CD4+ CD25+ T regulatory cells. This innovative method focuses on generating and expanding these cells in vitro, which can be utilized in the treatment of diseases associated with a cell-mediated immune response. Another notable patent involves a combined preparation containing IL-10 and rapamycin. This invention aims to induce immunosuppression and antigen-specific immune tolerance, providing a new approach to treating diseases characterized by excessive or dysfunctional immune responses mediated by T cells.
Career Highlights
Throughout her career, Manuela has worked with esteemed organizations such as Fondazione Telethon and Ospedale San Raffaele S.r.l. These institutions have provided her with a platform to advance her research and contribute to the scientific community.
Collaborations
Manuela has collaborated with notable professionals in her field, including Maria Grazia Roncarolo. Their partnership has fostered advancements in immunological research and therapeutic applications.
Conclusion
Manuela Battaglia's innovative work in immunology, particularly her patents and collaborations, highlights her significant role in advancing treatments for autoimmune diseases. Her contributions continue to pave the way for future research and development in this critical area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile